CoChat

The DOI matches its Crossref record; 185 of the 188 references it cites were found in a registry or an index.

Epigenetic Reprogramming in Mice and Humans: From Fertilization to Primordial Germ Cell Development

Open access

Abstract

In this review, advances in the understanding of epigenetic reprogramming from fertilization to the development of primordial germline cells in a mouse and human embryo are discussed. To gain insights into the molecular underpinnings of various diseases, it is essential to comprehend the intricate interplay between genetic, epigenetic, and environmental factors during cellular reprogramming and embryonic differentiation. An increasing range of diseases, including cancer and developmental disorders, have been linked to alterations in DNA methylation and histone modifications. Global epigenetic reprogramming occurs in mammals at two stages: post-fertilization and during the development of primordial germ cells (PGC). Epigenetic reprogramming after fertilization involves rapid demethylation of the paternal genome mediated through active and passive DNA demethylation, and gradual demethylation in the maternal genome through passive DNA demethylation. The de novo DNA methyltransferase enzymes, Dnmt3a and Dnmt3b, restore DNA methylation beginning from the blastocyst stage until the formation of the gastrula, and DNA maintenance methyltransferase, Dnmt1, maintains methylation in the somatic cells. The PGC undergo a second round of global demethylation after allocation during the formative pluripotent stage before gastrulation, where the imprints and the methylation marks on the transposable elements known as retrotransposons, including long interspersed nuclear elements (LINE-1) and intracisternal A-particle (IAP) elements are demethylated as well. Finally, DNA methylation is restored in the PGC at the implantation stage including sex-specific imprints corresponding to the sex of the embryo. This review introduces a novel perspective by uncovering how toxicants and stress stimuli impact the critical period of allocation during formative pluripotency, potentially influencing both the quantity and quality of PGCs. Furthermore, the comprehensive comparison of epigenetic events between mice and humans breaks new ground, empowering researchers to make informed decisions regarding the suitability of mouse models for their experiments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells12141874

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 DNA methylation levels during mouse and human embryo development from fertilization to PGC development. The methylation levels of the CpG islands are shown in the figure. The sperm genome is highly methylated (~75–80%), and the oocytes are relatively less methylated (~50%). After fertilization, global demethylation mediated by Tet enzymes occurs in the parental genomes, dropping the methylation to ~20% at the blastocyst stage. The process is rapid in the paternal genome and gradual in the maternal genome. The ICR remain methylated during this demethylation. The methylation is then restored gradually from the blastocyst stage to the gastrula stage by Dnmt3a and Dnmt3b enzymes. The inner cell mass (ICM) in the blastocyst is in naïve pluripotent stage, the epiblast comprises formative pluripotent state and beginning of gastrulation is primed pluripotency state before the cells divide into endoderm, mesoderm, and ectoderm by the end of gastrulation. PGCs first appear at E5.5 in the formative pluripotent stage and become prominent by E6.5. Dnmt1 maintains the DNA methylation levels in somatic cells. The second round of global demethylation occurs again in the PGC by the action of Tet enzymes. The PGCs have the least methylated genome in the entire lifespan of the mice as the parent-of-origin imprints are erased (~3–4%) [10] and new ones are established. The methylation of the sperm gradually increases by the action of Dnmt3a and Dnmt3b and is restored before birth. However, in oocytes, the methylation remains low and is restored at puberty. The timings for epigenetic events for both mice and humans are shown at the bottom of the figure.
Figure 1 DNA methylation levels during mouse and human embryo development from fertilization to PGC development. The methylation levels of the CpG islands are shown in the figure. The sperm genome is highly methylated (~75–80%), and the oocytes are relatively less methylated (~50%). After fertilization, global demethylation mediated by Tet enzymes occurs in the parental genomes, dropping the methylation to ~20% at the blastocyst stage. The process is rapid in the paternal genome and gradual in the maternal genome. The ICR remain methylated during this demethylation. The methylation is then restored gradually from the blastocyst stage to the gastrula stage by Dnmt3a and Dnmt3b enzymes. The inner cell mass (ICM) in the blastocyst is in naïve pluripotent stage, the epiblast comprises formative pluripotent state and beginning of gastrulation is primed pluripotency state before the cells divide into endoderm, mesoderm, and ectoderm by the end of gastrulation. PGCs first appear at E5.5 in the formative pluripotent stage and become prominent by E6.5. Dnmt1 maintains the DNA methylation levels in somatic cells. The second round of global demethylation occurs again in the PGC by the action of Tet enzymes. The PGCs have the least methylated genome in the entire lifespan of the mice as the parent-of-origin imprints are erased (~3–4%) [10] and new ones are established. The methylation of the sperm gradually increases by the action of Dnmt3a and Dnmt3b and is restored before birth. However, in oocytes, the methylation remains low and is restored at puberty. The timings for epigenetic events for both mice and humans are shown at the bottom of the figure.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 185 references

Cited by

See all 50

Metadata

Authors
Singh, A., Rappolee, D. A., & Ruden, D. M.
Affiliations
Wayne State University (US)
Corresponding author
Ruden, Douglas M.
Venue
Cells
Publisher
MDPI AG
Published
2023-07-17
Volume
12
Issue
14
Pages
1874
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4384695249
Cited by
50
References
188
Citations by year
2026: 19 · 2025: 13 · 2024: 16 · 2023: 2
FWCI
1.32
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
NIH (UH3OD023285, P42ES030991, P30ES020957)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
epigenetic reprogramming, primordial germ cell development, DNA demethylation, DNA methylation, histone modifications, DNMT3A, DNMT3B, DNMT1, LINE-1, genomic imprinting, toxic exposure, stress, human-mouse comparison, mouse model, blastocyst, gastrulation
MeSH terms
Animals, Cell Differentiation, DNA, Female, Fertilization, Germ Cells, Humans, Male, Mammals, Epigenesis, Genetic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetic Reprogramming in Mice and Humans: From Fertilization to Primordial Germ Cell Development. https://app.cochat.ai/papers/10.3390/cells12141874
The paper
Singh, A., Rappolee, D. A., & Ruden, D. M. (2023). Epigenetic Reprogramming in Mice and Humans: From Fertilization to Primordial Germ Cell Development. Cells. https://doi.org/10.3390/cells12141874

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.